Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study - Agnelli, G; Gussoni, G; Bianchini, C (Lancet Oncol, 2009)